BR112023017344A2 - Compostos que têm tetra-hidroindolizina-1-carboxamida como inibidores de bcl-2 - Google Patents
Compostos que têm tetra-hidroindolizina-1-carboxamida como inibidores de bcl-2Info
- Publication number
- BR112023017344A2 BR112023017344A2 BR112023017344A BR112023017344A BR112023017344A2 BR 112023017344 A2 BR112023017344 A2 BR 112023017344A2 BR 112023017344 A BR112023017344 A BR 112023017344A BR 112023017344 A BR112023017344 A BR 112023017344A BR 112023017344 A2 BR112023017344 A2 BR 112023017344A2
- Authority
- BR
- Brazil
- Prior art keywords
- bcl
- inhibitors
- tetrahydroindolizine
- carboxamide
- compounds
- Prior art date
Links
- IKQOMIXIZRXTAQ-UHFFFAOYSA-N 1,2,3,5-tetrahydroindolizine-1-carboxamide Chemical compound C1C=CC=C2C(C(=O)N)CCN21 IKQOMIXIZRXTAQ-UHFFFAOYSA-N 0.000 title abstract 2
- 239000012664 BCL-2-inhibitor Substances 0.000 title abstract 2
- 229940123711 Bcl2 inhibitor Drugs 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 108010090931 Proto-Oncogene Proteins c-bcl-2 Proteins 0.000 abstract 1
- 102000013535 Proto-Oncogene Proteins c-bcl-2 Human genes 0.000 abstract 1
- 208000037765 diseases and disorders Diseases 0.000 abstract 1
- 229940121649 protein inhibitor Drugs 0.000 abstract 1
- 239000012268 protein inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
compostos que têm tetra-hidroindolizina-1-carboxamida como inibidores de bcl-2. a presente invenção é geralmente direcionada a inibidores de proteínas bcl-2 úteis no tratamento de doenças e distúrbios modulados pela dita enzima e que tem a fórmula (i):
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163160208P | 2021-03-12 | 2021-03-12 | |
PCT/US2022/019998 WO2022192703A1 (en) | 2021-03-12 | 2022-03-11 | Compounds having tetrahydroindolizine-1-carboxamide as bcl-2 inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112023017344A2 true BR112023017344A2 (pt) | 2023-09-26 |
Family
ID=83195610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112023017344A BR112023017344A2 (pt) | 2021-03-12 | 2022-03-11 | Compostos que têm tetra-hidroindolizina-1-carboxamida como inibidores de bcl-2 |
Country Status (13)
Country | Link |
---|---|
US (1) | US11697650B2 (pt) |
EP (1) | EP4304588A1 (pt) |
JP (1) | JP2024508948A (pt) |
KR (1) | KR20230157419A (pt) |
CN (1) | CN116981458A (pt) |
AR (1) | AR125076A1 (pt) |
AU (1) | AU2022233461A1 (pt) |
BR (1) | BR112023017344A2 (pt) |
CA (1) | CA3211637A1 (pt) |
MX (1) | MX2023010692A (pt) |
TW (1) | TW202302585A (pt) |
UY (1) | UY39670A (pt) |
WO (1) | WO2022192703A1 (pt) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2986002B1 (fr) | 2012-01-24 | 2014-02-21 | Servier Lab | Nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR3008976A1 (fr) | 2013-07-23 | 2015-01-30 | Servier Lab | "nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent" |
FR3008979B1 (fr) * | 2013-07-23 | 2015-07-24 | Servier Lab | Nouveaux derives phosphates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
JP2022532335A (ja) | 2019-05-14 | 2022-07-14 | レ ラボラトワール セルヴィエ | GLY101VAL突然変異を有するBCL-2媒介性ガンの処置に使用するためのBcl-2阻害剤 |
-
2022
- 2022-03-11 WO PCT/US2022/019998 patent/WO2022192703A1/en active Application Filing
- 2022-03-11 US US17/692,923 patent/US11697650B2/en active Active
- 2022-03-11 UY UY0001039670A patent/UY39670A/es unknown
- 2022-03-11 CN CN202280021064.2A patent/CN116981458A/zh active Pending
- 2022-03-11 AU AU2022233461A patent/AU2022233461A1/en active Pending
- 2022-03-11 CA CA3211637A patent/CA3211637A1/en active Pending
- 2022-03-11 EP EP22768110.3A patent/EP4304588A1/en active Pending
- 2022-03-11 BR BR112023017344A patent/BR112023017344A2/pt unknown
- 2022-03-11 MX MX2023010692A patent/MX2023010692A/es unknown
- 2022-03-11 KR KR1020237034823A patent/KR20230157419A/ko unknown
- 2022-03-11 JP JP2023554297A patent/JP2024508948A/ja active Pending
- 2022-03-11 TW TW111108982A patent/TW202302585A/zh unknown
- 2022-03-11 AR ARP220100567A patent/AR125076A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
KR20230157419A (ko) | 2023-11-16 |
EP4304588A1 (en) | 2024-01-17 |
UY39670A (es) | 2022-07-29 |
US11697650B2 (en) | 2023-07-11 |
CA3211637A1 (en) | 2022-09-15 |
CN116981458A (zh) | 2023-10-31 |
MX2023010692A (es) | 2023-09-19 |
US20220289745A1 (en) | 2022-09-15 |
WO2022192703A1 (en) | 2022-09-15 |
TW202302585A (zh) | 2023-01-16 |
AR125076A1 (es) | 2023-06-07 |
AU2022233461A1 (en) | 2023-09-07 |
JP2024508948A (ja) | 2024-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2023013356A2 (es) | Compuestos para la inhibición de nlrp3 y usos de estos | |
BR112015021999A2 (pt) | inibidores de indoleamina 2,3-dioxigenase (ido) | |
MA38483A1 (fr) | Inhibiteurs de l'ido | |
BR112013010310A2 (pt) | inibidores de acetil-coa carboxilase de lactama n1/n2 | |
BR112012011072A2 (pt) | inibidores de n1-pirazolospirocetona acetil-coa carboxilase | |
CO2018010504A2 (es) | Inhibidores del enlace proteína-proteína de wdr5 | |
BR112021020520A2 (pt) | Inibidores da di-hidro-orotato desidrogenase | |
BR112020016020A8 (pt) | Inibidor de atr e aplicação do mesmo | |
MX2022007376A (es) | Fluoroalqull-oxadiazoles y sus usos. | |
BR112014000240A2 (pt) | derivados de benzilamina como inibidores de calicreína plasmática | |
BR112014013963A8 (pt) | compostos inibidores de metaloenzimas | |
BR112022000064A2 (pt) | Inibidores de hpk1 e usos dos mesmos | |
BR112018013522A2 (pt) | compostos inibidores de metaloenzima | |
ATE538651T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
BR112013031402A2 (pt) | derivados de hidantoína como inibidores de kv3 | |
EA200800777A1 (ru) | Применение сложных эфиров молочной кислоты для улучшения действия пестицидов | |
BR112023025358A2 (pt) | Inibidores de protease como antivirais | |
EA201291055A1 (ru) | Ингибиторы протеинтирозинкиназной активности и их применение для лечения глазных заболеваний | |
GT201700220A (es) | Derivados de pirazol útiles como inhibidores de proteína activadora de 5-lipoxigenasa (flap) | |
CO2023017082A2 (es) | Compuestos de tiadiazolilo unidos a un átomo de oxígeno como inhibidores de dna polimerasa θ | |
BR112022015110A2 (pt) | Compostos e usos dos mesmos | |
MX2018008903A (es) | COMPOSICIONES Y METODOS DE USO DE ß-HIDROXI-ß-METILBUTIRATO (HMB) PARA MODULAR AUTOFAGIA Y LIPOFAGIA. | |
BR112022015109A2 (pt) | Compostos e usos dos mesmos | |
BRPI0713743B8 (pt) | composto, e, composição farmacêutica | |
ATE538796T1 (de) | Piperidin- und pyrrolidin-beta-secretase-hemmer zur behandlung von alzheimer-krankheit |